Effective October 6, 2014, hydrocodone combination products (HCP), such as Vicodin and Lortab, have been reclassified from Schedule III to Schedule II drugs. This means doctors can no longer phone in a prescription for HCP’s and that patients must present a written prescription to the pharmacist.
View our PDF of the HCP reclassification.
Nitazenes: A Growing Threat in the Opioid Crisis
The opioid crisis has been a relentless public health challenge for years, but recently, a new and dangerous class of synthetic opioids has emerged: nitazenes. These potent drugs are...
